Floseal

Quick links to important sections

Floseal

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Floseal

The FLOSEAL Hemostatic Matrix is a specialized, two-component combination hemostatic agent used by surgeons as an adjunct to help control bleeding during various operations. Its purpose is to supplement standard surgical techniques like sutures or cautery, not replace them.


Quick Facts

Property Description
Active Ingredients Thrombin, Gelatin Matrix
Form Flowable Hemostatic Matrix (Sterile Hydrated Gel)
Pharmacological Class Adjunct Topical Hemostatic Agent
Common Use Achieving Hemostasis in Surgery
Origin Biologic/Derived (Bovine Gelatin, Human/Recombinant Thrombin)

What is Floseal and What Type of Agent is it?

Floseal is officially classified as an Absorbable Collagen Hemostatic Agent with Thrombin. It falls into the broader category of Adjunct Topical Hemostatic Agents because it assists surgeons in achieving hemostasis (stopping bleeding). Floseal's key distinctive feature is its flowable nature; the mixed product is a sterile, hydrated gel that is applied directly to the bleeding site for topical application. This unique consistency allows it to effectively fill and conform to irregular wound beds, which is challenging for non-flowable, solid hemostatic agents.

Composition and Origin: The Gelatin-Thrombin System

Floseal's efficacy is based on its two primary active entities: a cross-linked Gelatin Matrix and Thrombin. The Gelatin Matrix, which provides physical bulk and scaffolding, is bovine-derived. The Thrombin component, essential for activating clotting, may be sourced as either Human Thrombin or, in certain formulations, recombinant thrombin. The combination of these two components serves as an effective option for topical hemostasis during diverse surgical procedures. This specific type of flowable hemostat assists in achieving local blood control.

The General Purpose of Floseal in Surgery

The general purpose of Floseal is to achieve rapid and localized hemostasis during surgery. It works by combining a physical sealant with a biological activator to ensure immediate and sustained control. A typical use scenario involves its application in challenging surgical areas, such as liver resection or vascular procedures, where conventional methods may be inadequate. The entire matrix is bioresorbable, meaning the body naturally breaks it down and absorbs it over a period of weeks as the wound heals.

What side effects are possible with Floseal?

Possible side effects and safety information

The official safety profile for the FLOSEAL Hemostatic Matrix is defined by regulatory authorities and centers on risks related to its topical surgical use and biologic components (bovine gelatin, human/recombinant thrombin).

Documented Adverse Reactions and Risks

Adverse events reported in clinical trials and post-market surveillance cover several System-Organ Classes, reflecting both localized and systemic complications observed in the perioperative setting.

Category Key Safety Information from Regulatory Documents
Application Risks Thromboembolism (severe, potentially fatal clotting) is the primary serious risk if the material inadvertently enters the bloodstream (intravascular injection is strictly prohibited).
Immune System The product carries a risk of severe hypersensitivity reactions and anaphylaxis, which are linked to known or unknown allergies to its bovine-derived and thrombin components.
Common Observations Events classified as common (ge 3% incidence in clinical trials) include Anemia, Atrial Fibrillation, and Infection.
Site Constraints The material must not be used in the closure of skin incisions, in areas of frank infection, or in patients with known allergies to bovine materials.

Safety Considerations

The safety profile includes specific limitations based on available data. The safety and effectiveness have not been established in children under 2 years of age. Furthermore, it is not known whether use of the material can cause fetal harm during pregnancy.

Regulatory documents emphasize that safe use relies on the material remaining within the surgical site; if unremoved, the material may potentially lead to diagnostic imaging confusion or a foreign body reaction.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for FLOSEAL is structured around the serious risks associated with improper application rather than exceeding a therapeutic dose amount.

Regulators have explicitly warned against injecting the matrix material into blood vessels (intravascular injection) or applying it to vessels where blood flow is restricted (e.g., when a vessel is clamped).

Overdose Presentation (Regulatory Focus) Potential Consequences
Intravascular Injection/Compression Extensive intravascular clotting (thrombosis) and death
Injection into Vessel or Tissue Risk of allergic-anaphylactoid reaction and/or thromboembolic events, which may be life-threatening

These warnings emphasize that the unintended entry of the matrix material into the vascular system can lead to severe and systemic complications. The most critical documented risks are extensive blood clotting, thromboembolic events, and severe allergic reactions, which have been reported as potentially fatal outcomes.

Immediate medical help is required if a systemic reaction or complication is suspected following the application of this product. The key emergency action noted in the labeling is the necessity of immediate intervention to manage these life-threatening events.

Therapeutic Uses of Floseal

The FLOSEAL Hemostatic Matrix may assist with managing various types of bleeding during surgery, contributing to supportive relief in the therapeutic context of hemorrhage. Its application is commonly used in situations where conventional methods like sutures, ligatures, or cautery are not sufficient or practical. The matrix is commonly used in situations where managing bleeding with conventional procedures is less applicable or insufficient.

This product is relevant for easing symptom clusters related to persistent, diffuse bleeding (oozing) from soft tissue and cancellous bone, as well as managing hemorrhage in anatomically constrained areas like deep surgical cavities or irregular tissue structures. A key use is applied in clinical settings that involve acute or unstable symptom patterns, such as assisting with managing hemorrhage in fully anticoagulated patients during cardiac and vascular operations. The specialized application provides the support that helps ease the overall symptom burden associated with continuous blood loss, assisting with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Relief for Persistent Bleeding
FLOSEAL is commonly used to help with situations where pervasive, low-pressure surgical oozing is not easily addressed by standard hemostatic techniques.

Regulatory References

  1. FDA Instructions for Use

Eligibility and Restrictions for Use

Official Regulatory Eligibility for FLOSEAL Hemostatic Matrix

The eligibility for the use of FLOSEAL Hemostatic Matrix is strictly governed by contraindications and limitations documented in government-approved regulatory labeling.

Classification Eligibility Rule (Official Labeling)
Absolute Contraindications Do not use in patients with known allergies to materials of bovine origin.
Do not inject or compress into blood vessels (intravascular use is prohibited).
Populations with Non-Established Safety Safety and effectiveness have not been established in children or in pregnant women.
Conditional Use Restrictions Not recommended for use in the presence of an active infection.
Should not be used for the primary treatment of coagulation disorders.

Age and Physiological Status Rules

The product's safety and effectiveness have not been established in the pediatric population, often specified as children under 2 years of age. For pregnant women, use is not established and is only considered if clearly needed.

Specific Use Exclusions

The regulatory label strictly prohibits use in specific scenarios and surgical sites, including: closure of skin incisions, controlling post-partum bleeding or menorrhagia, and application to bone surfaces where acrylic adhesives are required. Safety and effectiveness have not been established for use in ophthalmic, neurosurgical, or urological procedures.

What should I know about interactions with other medicines?

The official interaction profile for FLOSEAL Hemostatic Matrix is structured around local compatibility constraints, as systemic drug-drug interactions involving metabolic enzymes or drug transporters are not documented in the regulatory labeling. The profile details three primary types of documented interactions and restrictions.


Interaction Scope

Scope Element Official Regulatory Information
Medicinal product categories with documented interactions: Topical adhesives, antiseptic solutions, and certain topical antibiotics.
Mechanistic basis of interactions (only if stated in label): Chemical denaturation; Physical interference; Immunologic pattern.

Official Interaction Statements

  • Contraindicated Combination: FLOSEAL should not be used in conjunction with methylmethacrylate or other acrylic adhesives on bone surfaces where these adhesives are required to attach a prosthetic device, as the collagen component may reduce the adhesive strength (Physical Interference).
  • Chemical Incompatibility and Timing Rule: The Thrombin component is subject to chemical denaturation by contact with antiseptic solutions containing alcohol, iodine, or heavy metal ions. The application site must be cleaned to remove these substances prior to use.
  • Co-administration Restriction: The safety and effectiveness of co-administration with antibiotic solutions or powders have not been established and is restricted.
  • Immunologic Pattern: Repeated clinical application of the bovine-derived components carries a risk of antibody formation that may cross-react with human Factor V, a pattern relevant to the coagulation system.

The regulatory documents define the product’s interaction structure predominantly through localized chemical and physical incompatibilities that govern its use at the surgical site. This profile also documents a unique immunological interaction pattern associated with the potential for adverse effects on the patient's coagulation system following repeated exposure to its components.

Mechanism of Action

Floseal's mechanism of action involves a dual mechanical and chemical pathway to modulate the coagulation cascade at the site of tissue damage. The product, a flowable gelatin-thrombin matrix, is applied directly to the bleeding surface. The bovine-derived gelatin matrix consists of cross-linked, spherical granules that selectively accumulate at the bleeding vasculature. Upon contact with blood, these granules undergo a rapid physical expansion, swelling approximately 10–20% within 10 minutes.

This physical expansion exerts a tamponade effect, restricting the local flow of blood. Simultaneously, the human-derived thrombin component interacts with circulating fibrinogen (biological target), acting as an enzyme to cleave fibrinogen into fibrin monomers. These monomers spontaneously polymerize to form an insoluble fibrin mesh. The gelatin matrix provides a localized scaffold, enhancing the concentration and surface area for this conversion, thereby promoting the accelerated formation of a mechanically stable fibrin-gelatin clot that integrates with the existing platelet plug. The system-level physiological consequence is the rapid, localized acceleration of secondary hemostasis via the common coagulation pathway.

Dosage and Administration Information

How to Use Floseal Hemostatic Matrix — Official Administration Guidelines

Floseal is a topical agent supplied as a kit that must be prepared immediately prior to use during a surgical procedure. The official instructions for use are strictly defined, and this information does not contain therapeutic indications or safety warnings.


Administration and Dosing

Administration Scope Official Requirement
Route Topical Administration Only (application to a bleeding surface). Do not inject into blood vessels.
Dosing Apply a sufficient amount to completely cover the bleeding site. Surgeons must account for the product's approximate 10% to 20% swelling volume after application, which is achieved within about 10 minutes.
Schedule Single use only during a procedure. After hemostasis is achieved, excess material must be removed by gentle irrigation and suctioning.

Preparation and Procedural Steps

  1. Preparation: The Gelatin Matrix and the Thrombin component must be reconstituted and mixed together just prior to use. The reconstituted Thrombin solution is quickly combined with the Gelatin Matrix.
  2. Mixing: The mixture is transferred back and forth between two connected syringes for a total of approximately 10 passes to achieve a uniformly mixed matrix.
  3. Use Window: The mixed Floseal Matrix is stable for use for up to 8 hours after the initial mixing process.
  4. Application: The matrix is extruded directly from the syringe, often via an attached applicator tip, onto the target bleeding site.
  5. Contact Time: The material is often left in place for approximately 2 minutes with gentle compression to facilitate clot formation.

Note: The safety and effectiveness of Floseal has not been established for use in children under 2 years of age.

Recent Clinical Evidence

Research evidence / Overview of studies for Floseal

Research for Floseal draws upon findings reported in official and peer-reviewed scientific literature, exploring its application over defined time intervals in various surgical fields. This research evaluated its application in the context of controlling blood loss by tracking measures like the time required to achieve local blood control and the rate of successful hemostasis in the operating room.


Evidence for Adjunct Hemostasis in General Surgery

The clinical evaluation for Floseal includes Randomized Controlled Trials (RCTs) and systematic reviews that examined the agent's application in a broad range of surgical procedures where standard hemostatic methods were being evaluated for sufficiency. These studies were designed to evaluate its use in adult populations. Researchers studied the Time to Hemostasis (TTH) and monitored complication rates related to bleeding. Analyses of the evidence base have noted variability and heterogeneity due to the wide range of procedures and control agents utilized.


Evidence for Use in Specialized Surgical Settings

Specific research has also explored the agent's application in environments that present unique challenges. Studies exploring use during cardiac surgery involved prospective RCTs and examined metrics related to TTH and the need for blood transfusions. In liver resection (hepatectomy), evidence primarily includes prospective and retrospective observational studies; the research base contains a limited number of large RCTs.

Evidence in Specific Patient Groups

Studies have primarily included adult populations; data for certain groups, such as children and pregnancy-related populations, remain insufficient or limited. Research has not fully examined the safety and effectiveness of the agent in pediatric populations.


Research Gaps and What is Still Uncertain

The evidence base shows several research limitations. The reliance on retrospective or observational database studies for certain surgical fields means that definitve comparative evidence is lacking, and research limitations constrain certainty regarding causal claims. While research highlights what is known for short-term changes, long-term effects are not fully established.

Frequently Asked Questions (FAQ)

Common questions about Floseal (FAQ)


Q: Are there any materials in Floseal that some people might be allergic to?

A: Official product information states that Floseal is strictly prohibited for use in patients who have known allergies to materials of bovine origin, as it contains bovine components. The product also carries a risk of severe hypersensitivity reactions and anaphylaxis, as described in official documents.

Q: Is Floseal safe for use in children?

A: According to regulatory documents, the safety and effectiveness of Floseal have not been established in children. Official product information states this lack of established data is specifically noted for children under 2 years of age.

Q: Is there any population group that cannot use Floseal, such as pregnant women?

A: Floseal is strictly contraindicated (prohibited) for use in patients with known allergies to bovine materials. For pregnant women, official information states it is not known if the use of Floseal can cause harm to the developing fetus, and it is only to be administered if clearly needed.

Q: Can Floseal affect healing in the long term?

A: Official information states that long-term effects are not fully established regarding the use of Floseal, which means long-term data on potential impacts are unavailable.

Q: What are the most commonly reported side effects related to Floseal?

A: Clinical trials reported a few events classified as common (occurring in 3% or more of patients). These commonly observed side effects include Anemia, Atrial Fibrillation (an irregular heart rhythm), and Infection.

Q: Can Floseal cause problems with imaging tests like X-rays or MRIs later on?

A: Official warnings note that if unremoved material remains at the application site, it may potentially cause diagnostic imaging confusion due to its appearance on scans.

Q: What is the primary difference between the thrombin component and the gelatin matrix in Floseal?

A: Floseal achieves hemostasis (stopping blood flow) through a dual action. The gelatin matrix provides a physical scaffold and swells to create a mechanical tamponade effect (physical pressure). The thrombin component is the biological activator, which chemically triggers the conversion of fibrinogen into fibrin to accelerate the formation of a stable, natural clot.

Q: Does Floseal have a shelf life or specific storage requirements before the operation?

A: Yes, the Floseal kit must be stored between 2 C and 25 C (36 F to 77 F) and must not be frozen. Once components are prepared for use during surgery, the prepared matrix is stable for application for up to eight hours.

Q: Is Floseal the same as a traditional gauze or bandage?

A: No, Floseal is regulated as a flowable, dual-action hemostatic agent that is applied as a matrix. It is designed to actively participate in the clotting process, unlike non-flowable, passive hemostats.

Q: How is Floseal different from other products used for bleeding during surgery?

A: Floseal is characterized by its flowable consistency, which allows it to conform to and fill irregular wound beds. This property, combined with its dual mechanical and chemical mechanism, distinguishes it from non-flowable hemostatic agents.

Q: Is Floseal fully absorbed by the body?

A: Yes, Floseal is a bioresorbable product. This means the body’s natural processes are expected to break down and absorb the entire matrix material over a period of approximately 6 to 8 weeks as the wound heals.

Q: What should be done if someone experiences an unexpected reaction after a procedure involving Floseal?

A: Patients who experience any unexpected symptoms or reactions following a procedure where Floseal was used should report this to their physician or other qualified healthcare provider immediately.

Q: How quickly does Floseal start to work during a surgery?

A: Official instructions for use are focused on the application procedure. They specify that the material is typically left in place for approximately two minutes with gentle compression to facilitate the localized formation of the blood clot.

Q: Is a fever or mild swelling normal after a procedure where Floseal was used?

A: Fever is sometimes mentioned in official literature, primarily in the context of infectious agents that are a theoretical risk due to human components. Infection itself is listed as a common post-operative observation in clinical trials.

Q: Does the application of Floseal require special training for the surgeon?

A: Floseal is a prescription-only (Rx Only) product and is applied by a qualified surgeon or healthcare professional. The label notes that Floseal is not intended as a substitute for meticulous surgical technique.

Q: Why is the preparation of Floseal specific before use?

A: The components (gelatin matrix and thrombin) must be reconstituted and mixed together just before application to achieve optimal product consistency. The specific mixing technique ensures the thrombin activator is uniformly distributed throughout the flowable matrix.

Q: Is Floseal regulated as a drug or a medical device?

A: Floseal is regulated as a medical device by the FDA. It is officially classified as an Absorbable Collagen Hemostatic Agent with Thrombin.

Q: How does Floseal compare to oxidized cellulose products?

A: Floseal is a flowable, dual-action hemostatic matrix combining physical action with a biological clotting activator. Oxidized cellulose is generally a non-flowable, passive hemostat that works mainly through mechanical action.

Q: What is known about Floseal's use in patients with compromised immune systems?

A: Due to the theoretical risk of transmitting infectious agents, official information includes the factor that this risk most seriously affects pregnant women or immune-compromised individuals. Official information includes this factor in the safety profile related to potential infectious agents.

Q: Does Floseal contain any antibiotics or pain relievers?

A: Floseal contains only a gelatin matrix and thrombin. Official product information states that the safety and effectiveness of using Floseal in combination with antibiotic solutions or powders have not been established.

Q: How does Floseal help control bleeding in hard-to-reach areas?

A: The material’s unique flowable design and consistency are key to its intended purpose. This property allows the matrix to easily fill and conform to irregular wound surfaces, voids, and challenging anatomical locations.

Q: Is Floseal available outside of hospital settings?

A: Floseal is a prescription-only (Rx Only) product. It is intended for application by a surgeon or other qualified healthcare professional within a surgical or clinical environment, meaning it is not available for consumer purchase.

Q: Could Floseal affect the performance of metal implants?

A: Official labeling strictly prohibits the use of Floseal on bone surfaces where acrylic adhesives (like methylmethacrylate) will be required to attach a prosthetic device. Components in Floseal have been reported to reduce the adhesive strength of these materials.

Q: Is Floseal used in all types of surgery, including neurosurgery?

A: No, official regulatory documents state that the safety and effectiveness for use in certain procedures, including neurosurgical and urological procedures, have not been established through randomized clinical studies.

How should Floseal be stored and disposed of?

The storage and disposal of FloSeal Hemostatic Matrix are governed by specific regulatory requirements to maintain its sterility and function.


Storage and Stability

The FloSeal kit must be stored at a temperature between 2 C to 25 C (36 F to 77 F), and it is explicitly required to not freeze the product. The kit must also be stored in a dry place and protected from light.


Component Stability Time Limit
Reconstituted Thrombin Solution Up to four hours at 2 C to 25 C
Prepared FloSeal Matrix Up to eight hours within the sterile field

Handling and Disposal

FloSeal is a single-use, sterile product and must not be re-sterilized. If the packaging is damaged or opened, the product should not be used. All unused components, such as the Thrombin solution and vial, must be discarded appropriately. Any excess material remaining after application must be removed by gentle irrigation and suction.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Floseal found in:

A-Z Index: